Neurostimulation for Bladder Pain Syndrome

  • Dominique El-Khawand
  • Kristene E. Whitmore


Bladder pain syndrome (BPS) can be a debilitating disorder with limited treatment options. Recently, neuromodulation has emerged as a viable therapeutic option for patients with intractable symptoms, improving the pain and the urgency–frequency, as well as the quality of life. The most commonly used approach is sacral nerve stimulation (SNS), although pudendal and posterior tibial nerve stimulations have also been described. This chapter details the mechanism of action, patient selection, and procedure technique of SNS. It also reviews the latest scientific literature addressing its use for BPS, and provides a summary of the reported related adverse events. Furthermore, it sheds some light on the current research regarding pudendal, posterior tibial, and caudal epidural sacral nerve stimulations.


Interstitial Cystitis Pudendal Nerve Sacral Nerve Stimulation Implantable Pulse Generator Bladder Pain Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Tanagho EA, Schmidt RA. Electrical stimulation in the clinical management of the neurogenic bladder. J Urol. 1988;140(6):1331–9.PubMedGoogle Scholar
  2. 2.
    de Groat WC. A neurologic basis for the overactive bladder. Urology. 1997;50(6A Suppl):36–52. discussion 53–36.PubMedCrossRefGoogle Scholar
  3. 3.
    Habler HJ, Janig W, Koltzenburg M. Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat. J Physiol. 1990;425:545–62.PubMedGoogle Scholar
  4. 4.
    McMahon SB. Neuronal and behavioural consequences of chemical inflammation of rat urinary bladder. Agents Actions. 1988;25(3–4):231–3.PubMedCrossRefGoogle Scholar
  5. 5.
    Whitmore KE, Payne CK, Diokno AC, Lukban JC. Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14(5):305–8. discussion 308–309.PubMedCrossRefGoogle Scholar
  6. 6.
    Shaker H, Wang Y, Loung D, Balbaa L, Fehlings MG, Hassouna MM. Role of C-afferent fibres in the mechanism of action of sacral nerve root neuromodulation in chronic spinal cord injury. BJU Int. 2000;85(7):905–10.PubMedCrossRefGoogle Scholar
  7. 7.
    Hohenfellner M, Dahms SE, Matzel K, Thuroff JW. Sacral neuromodulation for treatment of lower urinary tract dysfunction. BJU Int. May 2000;85 Suppl 3:10–9. discussion 22–13.PubMedGoogle Scholar
  8. 8.
    Fowler CJ, Swinn MJ, Goodwin RJ, Oliver S, Craggs M. Studies of the latency of pelvic floor contraction during peripheral nerve evaluation show that the muscle response is reflexly mediated. J Urol. 2000;163(3):881–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150(699):971–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Elkelini MS, Abuzgaya A, Hassouna MM. Mechanisms of action of sacral neuromodulation. Int Urogynecol J Pelvic Floor Dysfunct. 2010;21 Suppl 2:S439–46.Google Scholar
  11. 11.
    Yoo PB, Woock JP, Grill WM. Bladder activation by selective stimulation of pudendal nerve afferents in the cat. Exp Neurol. 2008;212(1):218–25.PubMedCrossRefGoogle Scholar
  12. 12.
    Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32(1):11–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Williams ER, Siegel SW. Procedural techniques in sacral nerve modulation. Int Urogynecol J Pelvic Floor Dysfunct. 2010;21 Suppl 2:453–60.Google Scholar
  14. 14.
    Baxter C, Kim JH. Contrasting the percutaneous nerve evaluation versus staged implantation in sacral neuromodulation. Curr Urol Rep. 2010;11(5):310–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Borawski KM, Foster RT, Webster GD, Amundsen CL. Predicting implantation with a neuromodulator using two different test stimulation techniques: a prospective randomized study in urge incontinent women. Neurourol Urodyn. 2007;26(1):14–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Bannowsky A, Wefer B, Braun PM, Junemann KP. Urodynamic changes and response rates in patients treated with permanent electrodes compared to conventional wire electrodes in the peripheral nerve evaluation test. World J Urol. 2008;26(6):623–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Maher CF, Carey MP, Dwyer PL, Schluter PL. Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis. J Urol. 2001;165(3):884–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol. 2003;169(4):1369–73.PubMedCrossRefGoogle Scholar
  19. 19.
    Peters KM, Konstandt D. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int. 2004;93(6):777–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Chai TC, Zhang C, Warren JW, Keay S. Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis. Urology. 2000;55(5):643–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Powell CR, Kreder KJ. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol. 2010;183(1):173–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Gajewski JB, Al-Zahrani AA. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre. BJU Int. 2010;107(8):1258–64.PubMedCrossRefGoogle Scholar
  23. 23.
    Leong RK, De Wachter SG, van Kerrebroeck PE. Current information on sacral neuromodulation and botulinum toxin treatment for refractory idiopathic overactive bladder syndrome: a review. Urol Int. 2010;84(3):245–53.PubMedCrossRefGoogle Scholar
  24. 24.
    Brazzelli M, Murray A, Fraser C. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol. 2006;175(3 Pt 1):835–41.PubMedCrossRefGoogle Scholar
  25. 25.
    Sutherland SE, Lavers A, Carlson A, Holtz C, Kesha J, Siegel SW. Sacral nerve stimulation for voiding dysfunction: one institution’s 11-year experience. Neurourol Urodyn. 2007;26(1):19–28. discussion 36.PubMedCrossRefGoogle Scholar
  26. 26.
    Deng DY, Gulati M, Rutman M, Raz S, Rodriguez LV. Failure of sacral nerve stimulation due to migration of tined lead. J Urol. 2006;175(6):2182–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Peters KM, Feber KM, Bennett RC. Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial. Neurourol Urodyn. 2005;24(7):643–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Peters KM, Feber KM, Bennett RC. A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis. BJU Int. 2007;100(4):835–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Peters KM, Killinger KA, Boguslawski BM, Boura JA. Chronic pudendal neuromodulation: expanding available treatment options for refractory urologic symptoms. Neurourol Urodyn. 2010;29(7):1267–71.PubMedCrossRefGoogle Scholar
  30. 30.
    Congregado Ruiz B, Pena Outeirino XM, Campoy Martinez P, Leon Duenas E, Leal Lopez A. Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol. 2004;45(1):65–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Zhao J, Nordling J. Posterior tibial nerve stimulation in patients with intractable interstitial cystitis. BJU Int. 2004;94(1):101–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Zhao J, Bai J, Zhou Y, Qi G, Du L. Posterior tibial nerve stimulation twice a week in patients with interstitial cystitis. Urology. 2008;71(6):1080–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Zabihi N, Mourtzinos A, Maher MG, Raz S, Rodriguez LV. Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(4):553–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and GynecologyDrexel University College of MedicinePhiladelphiaUSA

Personalised recommendations